The protective effect of Borago Officinalis extract on amyloid β (25–35)-induced long term potentiation disruption in the dentate gyrus of male rats

Metabolic Brain Disease

Volumn 30, Issue 1, 2015, Pages 151-156

  Zargooshnia, Somayeh ^a   Shahidi, Siamak ^a   Ghahremanitamadon, Fatemeh ^a   Nikkhah, Ali ^a   Mehdizadeh, Mehdi ^b   Soleimani Asl, Sara ^a,c  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alzheimer disease; Amyloid peptide; Borago Officinalis; Hippocampus; Long term potentiation

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (25-35); ANTIOXIDANT; PEPTIDE FRAGMENT; PLANT EXTRACT; THIOL DERIVATIVE;

ANIMAL; BORAGO; CHEMICALLY INDUCED; CHEMISTRY; DENTATE GYRUS; DRUG EFFECTS; DRUG SCREENING; HIPPOCAMPUS; INJECTION; LONG TERM POTENTIATION; MALE; MEMORY DISORDERS; PHYTOTHERAPY; RANDOMIZATION; RAT; WISTAR RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; ANTIOXIDANTS; BORAGO; DENTATE GYRUS; DRUG EVALUATION, PRECLINICAL; HIPPOCAMPUS; INJECTIONS; LONG-TERM POTENTIATION; MALE; MEMORY DISORDERS; PEPTIDE FRAGMENTS; PHYTOTHERAPY; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS;

EID: 84940280931     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-014-9594-4     Document Type: Article

References (28)

1. Al-Saidi W, Al-Yawer M, Mangalo H, Hammoudi SR (2006) Elucidation of a role for the aqueous extract of borage in mammary gland growth and development Iraqi postgraduate. Med J 5:54–61
2. Ashenafi S, Fuente A, Criado JM, Riolobos AS, Heredia M, Yajeya J (2005) β-Amyloid peptide (25–35) depresses excitatory synaptic transmission in the rat basolateral amygdala “in vitro”. Neurobiol Aging 26:419–428
3. Brureau A, Zussy C, Delair B, Ogier C, Ixart G, Maurice T, Givalois L (2013) Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer’s disease rat model. Neurobiol Aging 34:1426–1439
4. Butterfield DA, Lauderback CM (2002) Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radic Biol Med 32:1050–1060
5. Conforti F et al (2008) In vivo anti-inflammatory and in vitro antioxidant activities of Mediterranean dietary plants. J Ethnopharmacol 116:144–151
6. Cunningham AJ, Murray CA, O’Neill LAJ, Lynch MA, O’Connor JJ (1996) Interleukin-1β and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203:17–20
7. Deshpande A, Mina E, Glabe C, Busciglio J (2006) Different conformations of amyloid β induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26:6011–6018
8. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77
9. Freir DB, Costello DA, Herron CE (2003) Aβ (25–35) -induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil. J Neurophysiol 89:3061–3069
10. Geronikaki AA, Gavalas AM (2006) Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity. Comb Chem High Throughput Screen 9:425–442
11. Gilani AH, Bashir S, A-u K (2007) Pharmacological basis for the use of Borago officinalis in gastrointestinal, respiratory and cardiovascular disorders. J Ethnopharmacol 114:393–399
12. Harbige LS, Layward L, Morris-Downes MM, Dumonde DC, Amor S (2000) The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-β1) up-regulation and increased prostaglandin E2 (PGE2) production. Clin Exp Immunol 122:445–452
13. Huang Y-S, Lin X, Redden PR, Horrobin DF (1995) In vitro hydrolysis of natural and synthetic γ-linolenic acid-containing triacylglycerols by pancreatic lipase. J Am Oil Chem Soc 72:625–631
14. Lisman JE, Grace AA (2005) The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 46:703–713
15. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP (1997) A Role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid- β peptide. J Neurochem 68:255–264
16. McGahon BM, Murray CA, Horrobin DF, Lynch MA (1999) Age-related changes in oxidative mechanisms and LTP are reversed by dietary manipulation. Neurobiol Aging 20:643–653
17. Murkovic M (2002) The detection of radical scavenging compounds in crude extract of borage (Borago officinalis L.) by using an on-line HPLC-DPPH method. J Biochem Biophys Methods 53:45–49
18. Paxinos G, Watson C, Pennisi M, Topple A (1985) Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J Neurosci Methods 13:139–143
19. Peng QL, Buz’Zard AR, Lau BHS (2002) Pycnogenol® protects neurons from amyloid-β peptide-induced apoptosis. Mol Brain Res 104:55–65
20. Sadeghnia HR, Kamkar M, Assadpour E, Boroushaki MT, Ghorbani A (2013) Protective effect of safranal, a constituent of Crocus sativus, on quinolinic acid-induced oxidative damage in rat hippocampus. Iran J Basic Med Sci 16:73–82
21. Selkoe DJ (1991) The molecular pathology of Alzheimer’s disease. Neuron 6:487–498
22. Selkoe DJ (2002) Alzheimer’s disease is a synaptic failure. Science 298:789–791
23. Shankar GM et al (2008) Amyloid-β protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 14:837–842
24. Stepanichev MY, Zdobnova IM, Zarubenko II, Moiseeva YV, Lazareva NA, Onufriev MV, Gulyaeva NV (2004) Amyloid-β (25–35)-induced memory impairments correlate with cell loss in rat hippocampus. Physiol Behav 80:647–655
25. Sutton ET, Thomas T, Bryant MW, Landon CS, Newton CA, Rhodin JA (1999) Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1. J Submicrosc Cytol Pathol 31:313
26. Tohda C, Tamura T, Komatsu K (2003) Repair of amyloid β (25–35)-induced memory impairment and synaptic loss by a Kampo formula, Zokumei-to. Brain Res 990:141–147
27. Trubetskaya VV, Stepanichev MY, Onufriev MV, Lazareva NA, Markevich VA, Gulyaeva NV (2003) Administration of aggregated beta-amyloid peptide (25–35) induces changes in long-term potentiation in the hippocampus in vivo. Neurosci Behav Physiol 33:95–98
28. Wang Q, Walsh DM, Rowan MJ, Selkoe DJ, Anwyl R (2004) Block of long-term potentiation by naturally secreted and synthetic amyloid β- peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J Neurosci 24:3370–3378